Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Proietto

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Endocrinology|October 24, 2015
Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO miceSofianos Andrikopoulos, Barbara C Fam, Anita Holdsworth, et al.
Arthritis Care & Research|October 6, 2011
Relationship between obesity and foot pain and its association with fat mass, fat distribution, and muscle massStephanie K Tanamas, Anita E Wluka, Patricia Berry, et al.
Diabetes|April 1, 2008
Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell functionMelkam Kebede, Jenny Favaloro, Jenny E Gunton, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registryTerase Lancefield, David J Clark, Nick Andrianopoulos, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Diabetes|April 21, 2012
The role of liver fructose-1,6-bisphosphatase in regulating appetite and adipositySherley Visinoni, Nurul Fathiah Izzati Khalid, Christos N Joannides, et al.
Diabetes Care|August 16, 2014
Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind studyRichard W Simpson, Geoffrey C Nicholson, Joseph Proietto, et al.
The Journal of Biological Chemistry|June 29, 2005
Socs1 deficiency enhances hepatic insulin signalingEmma Jamieson, Mark M W Chong, Gregory R Steinberg, et al.
Molecular Metabolism|March 16, 2016
Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult miceChrysovalantou E Xirouchaki, Salvatore P Mangiafico, Katherine Bate, et al.
Hepatology (Baltimore, Md.)|August 28, 2010
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesityNirupa Sachithanandan, Barbara C Fam, Stacey Fynch, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Endocrinology|October 24, 2015
Identification of ABCC8 as a contributory gene to impaired early-phase insulin secretion in NZO miceSofianos Andrikopoulos, Barbara C Fam, Anita Holdsworth, et al.
Arthritis Care & Research|October 6, 2011
Relationship between obesity and foot pain and its association with fat mass, fat distribution, and muscle massStephanie K Tanamas, Anita E Wluka, Patricia Berry, et al.
Diabetes|April 1, 2008
Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell functionMelkam Kebede, Jenny Favaloro, Jenny E Gunton, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registryTerase Lancefield, David J Clark, Nick Andrianopoulos, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Diabetes|April 21, 2012
The role of liver fructose-1,6-bisphosphatase in regulating appetite and adipositySherley Visinoni, Nurul Fathiah Izzati Khalid, Christos N Joannides, et al.
Diabetes Care|August 16, 2014
Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind studyRichard W Simpson, Geoffrey C Nicholson, Joseph Proietto, et al.
The Journal of Biological Chemistry|June 29, 2005
Socs1 deficiency enhances hepatic insulin signalingEmma Jamieson, Mark M W Chong, Gregory R Steinberg, et al.
Molecular Metabolism|March 16, 2016
Impaired glucose metabolism and exercise capacity with muscle-specific glycogen synthase 1 (gys1) deletion in adult miceChrysovalantou E Xirouchaki, Salvatore P Mangiafico, Katherine Bate, et al.
Hepatology (Baltimore, Md.)|August 28, 2010
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesityNirupa Sachithanandan, Barbara C Fam, Stacey Fynch, et al.
Pageof 10